ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 294,37
0,00%
Dow Jones
42 342,24
0,04%
DAX
19 969,86
-1,44%
Brent Oil
72,38
-0,01%
Bitcoin
96 398,09
-1,09%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Lifecore Biomedical Inc (LFCR) Cours

Lifecore Biomedical Inc

Lifecore Biomedical Inc (LFCR)

NASDAQ
7,07
0,13
(1,87%)
Fermé 20 Décembre 10:00PM
Retardé de 15 minutes
7,07
0,00
(0,00%)
Après les heures de négociation: 1:43AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
7,07
Prix Achat
6,74
Prix Vente
8,31
Volume échangé
203 677
6,87 Fourchette du Jour 7,16
3,6793 Plage de 52 semaines 8,90
Cap du marché
218,451M
Clôture Veille
6,94
Ouverture
7,035
Dernière Transaction
185
@
7.07
(priorref)
Dernière heure de transaction
Volume financier
US$ 1 431 144
VWAP
7,0265
Volume moyen (3 m)
171 477
Actions en circulation
30 898 255
Rendement du Dividende
-
Ratio Cours sur Bénéfices
18,18
Bénéfice par action (BPA)
0,39
Chiffre d'affairess
128,26M
Bénéfice net
12,01M

À propos de Lifecore Biomedical Inc

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hy... Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Show more

Secteur
Plastics,resins,elastomers
Industrie
Plastics,resins,elastomers
Site Web
www.lifecore.com
Siège social
Wilmington, Delaware, USA
Fondé
-
Lifecore Biomedical Inc est coté dans le secteur Plastics,resins,elastomers de la NASDAQ avec le ticker LFCR. Le dernier cours de clôture d'Lifecore Biomedical était de US$6,94. Au cours de la dernière année, les actions de Lifecore Biomedical ont été négociées dans une fourchette de prix de US$ 3,6793 à US$ 8,90.

Lifecore Biomedical compte actuellement 30 898 255 actions en circulation. La capitalisation boursière d'Lifecore Biomedical est de US$214,43 million. Lifecore Biomedical a un ratio cours/bénéfice (ratio PE) de 18.18.

LFCR Dernières nouvelles

Plus de nouvelles

Lifecore Biomedical to Report Financial Results for Second Quarter of Fiscal 2025 on January 2, 2025

CHASKA, Minn., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

il y a 10 heures
GlobeNewswire Inc.

Lifecore Biomedical Selected by Nirsum Labs to Provide CDMO Services Supporting Clinical Development of Innovative Opioid Use Disorder Treatment

Development Services Span Tech Transfer, Process Assessment and Method Validation for Fill and Finish of NRS-033 for Planned Phase 2 Trial Lifecore to Leverage Differentiated Capabilities and...

il y a 19 heures
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

10 Décembre 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

10 Décembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

26 Novembre 2024
Edgar (US Regulatory)

Lifecore Biomedical Amends and Extends Revolving Credit Facility with BMO

Three-Year Term Extension Combined with Simplification and Reduction of Interest Rates Helps Further Strengthen Company’s Balance Sheet and Overall Financial Position Builds Upon Other Recent...

26 Novembre 2024
GlobeNewswire Inc.

Lifecore Biomedical Hosts Virtual Investor Day

CHASKA, Minn., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

21 Novembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

21 Novembre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

20 Novembre 2024
Edgar (US Regulatory)

Lifecore Biomedical to Present at Stephens Annual Investment Conference

CHASKA, Minn., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...

12 Novembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.6-7.822685788797.677.886.851696447.44132236CS
4-0.4-5.35475234277.477.996.831902027.3803528CS
122.3148.52941176474.767.994.331714776.43263767CS
262.1142.54032258064.967.993.67932162295.49032005CS
521.0617.63727121466.018.93.67931957065.82717019CS
156-2.01-22.13656387679.0811.4551.523192265.86654186CS
260-2.01-22.13656387679.0811.4551.523192265.86654186CS

LFCR - Frequently Asked Questions (FAQ)

What is the current Lifecore Biomedical share price?
The current share price of Lifecore Biomedical is US$ 7,07
How many Lifecore Biomedical shares are in issue?
Lifecore Biomedical has 30 898 255 shares in issue
What is the market cap of Lifecore Biomedical?
The market capitalisation of Lifecore Biomedical is USD 214,43M
What is the 1 year trading range for Lifecore Biomedical share price?
Lifecore Biomedical has traded in the range of US$ 3,6793 to US$ 8,90 during the past year
What is the PE ratio of Lifecore Biomedical?
The price to earnings ratio of Lifecore Biomedical is 18,18
What is the cash to sales ratio of Lifecore Biomedical?
The cash to sales ratio of Lifecore Biomedical is 1,7
What is the reporting currency for Lifecore Biomedical?
Lifecore Biomedical reports financial results in USD
What is the latest annual turnover for Lifecore Biomedical?
The latest annual turnover of Lifecore Biomedical is USD 128,26M
What is the latest annual profit for Lifecore Biomedical?
The latest annual profit of Lifecore Biomedical is USD 12,01M
What is the registered address of Lifecore Biomedical?
The registered address for Lifecore Biomedical is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Lifecore Biomedical website address?
The website address for Lifecore Biomedical is www.lifecore.com
Which industry sector does Lifecore Biomedical operate in?
Lifecore Biomedical operates in the PLASTICS,RESINS,ELASTOMERS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PRFXPainReform Ltd
US$ 11,08
(410,60%)
95,4M
NVNINVNI Group Ltd
US$ 2,66
(315,63%)
20,64M
BPTHBio Path Holdings Inc
US$ 1,50
(124,22%)
113,42M
ZCARZoomcar Holdings Inc
US$ 2,5999
(96,96%)
18,03M
APCXAppTech Payments Corporation
US$ 0,6203
(62,81%)
196,08M
LITMSnow Lake Resources Ltd
US$ 0,3025
(-63,09%)
72,24M
BSFCBlue Star Foods Corporation
US$ 0,1478
(-48,14%)
7,45M
QUBTQuantum Computing Inc
US$ 15,1396
(-41,05%)
122,47M
QMCOQuantum Corporation
US$ 36,02
(-39,99%)
7,07M
AEMDAethlon Medical Inc
US$ 0,4232
(-35,94%)
9,52M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,561
(53,78%)
725,18M
NVDANVIDIA Corporation
US$ 130,68
(1,37%)
209,74M
APCXAppTech Payments Corporation
US$ 0,6203
(62,81%)
196,08M
RGTIRigetti Computing Inc
US$ 7,465
(-30,17%)
176,12M
SOUNSoundHound AI Inc
US$ 18,855
(-9,55%)
139,39M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
LFCR
Lifecore Biomedical
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés